MARKED AND PROLONGED DEPRESSION OF FACTOR-XIII AFTER ESOPHAGEAL RESECTION

被引:5
作者
SAITO, H
FUKUSHIMA, R
KOBORI, O
KAWANO, N
MUTO, T
MORIOKA, Y
机构
[1] The First Department of Surgery, University of Tokyo, Tokyo, 113, 7-3-1 Hongo, Bunkyoku
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1992年 / 22卷 / 03期
关键词
FACTOR-XIII; ESOPHAGECTOMY; WOUND HEALING;
D O I
10.1007/BF00308823
中图分类号
R61 [外科手术学];
学科分类号
摘要
Anastomotic leakage is one of the most common complications of esophagectomy and, since Factor XIII is required for normal wound healing, we investigated the temporal changes in plasma Factor XIII following esophagectomy and hepatectomy. A control group of patients undergoing other abdominal operations was also studied. Factor XIII activity was determined before surgery and on postoperative days (POD) 1, 3, 7 and 14. The plasma levels of acute phase protein were also measured. The plasma Factor XIII activity decreased significantly in both the hepatectomy and control groups until POD 7, reaching the lowest level on POD 3. In contrast, the esophagectomy group showed significant decreases in Factor XIII levels throughout the postoperative study period, with a nadir with an average activity of 56 per cent on POD 7. Preoperative transferrin levels had a positive correlation with Factor XIII levels measured on POD 3 and there was also a positive significant correlation between Factor XIII activity and alpha 2-macroglobulin levels on POD 3. These results suggest that there is a marked and prolonged depression of plasma Factor XIII activity following esophagectomy which may be attributed to accelerated tissue demands, inadequate synthesis or increased degradation. Moreover, the severe and sustained decrease in Factor XIII activity may be related to poor wound healing after esophagectomy .
引用
收藏
页码:201 / 206
页数:6
相关论文
共 23 条
[1]  
Giuli R., Sancho-Garnier H., Diagnostic, therapeutic, and prognostic features of cancers of the esophagus: Results of the international prospective study conducted by the OESO group (790 Patients), Surgery, 99, pp. 614-622, (1986)
[2]  
Postlethwait R.W., Durham N.C., Complications and death after operations for esophageal carcinoma, J Thorac Surg, 85, pp. 827-831, (1983)
[3]  
McDonagh J., Structure and function of factor XIII, Hemostasis and thrombosis, pp. 164-173, (1982)
[4]  
Duckert F., Documentation of the plasma factor XIII deficiency in man, Ann NY Acad Sci, 202, pp. 190-199, (1972)
[5]  
Beck E., Duckert F., Ernst M., The influence of Fibrin stabilizing factor on the growth of fibroblasts in vitro and wound healing, Thromb Diath Haemorrh, 6, pp. 485-497, (1961)
[6]  
Ueyama M., Urayama T., The role of factor XIII in fibroblast proliferation, Jpn J Exp Med, 48, pp. 135-142, (1978)
[7]  
Matsuda Y., Wound healing and factor XIII, Acta Haem Jap, 40, pp. 995-1002, (1977)
[8]  
Hosenfeld D., Dunnweber E., Kaiser N., Das Verhalten des Faktors XIII nach Operation. 2. Mitteilung, Med Welt, 20, pp. 1170-1173, (1969)
[9]  
Lehteby B.A., Davis R.B., Lasen A.E., The effect of major surgical procedures on plasma and platelet levels of factor XIII, Thromb Diath Haemorrh, 31, pp. 20-29, (1974)
[10]  
Kidess E., Miller H., Preisner A., Briel R., Factor XIII levels in relation to gynaecological operation, Arch Gynecol, 227, pp. 163-169, (1979)